FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

773838001: Antimigraine therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3726730017 Antimigraine therapeutic role (role) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3726731018 Antimigraine therapeutic role en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antimigraine therapeutic role Is a Therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Medicinal product acting as antimigraine agent (product) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing only fremanezumab in parenteral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing fremanezumab in parenteral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing lasmiditan (medicinal product) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing only ubrogepant (medicinal product) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing ubrogepant in oral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing ubrogepant (medicinal product) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing only ubrogepant in oral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing rimegepant (medicinal product) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Rimegepant Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing only rimegepant in oral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing rimegepant in oral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely lasmiditan 50 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing only lasmiditan (medicinal product) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing lasmiditan in oral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing only lasmiditan in oral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing only eptinezumab in parenteral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing eptinezumab (medicinal product) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Eptinezumab Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing eptinezumab in parenteral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely rimegepant (as rimegepant sulfate) 75 milligram/1 each conventional release orodispersible tablet (clinical drug) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing rimegepant in oromucosal dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing only rimegepant in oromucosal dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely fremanezumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing pizotifen in oral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely pizotifen 500 microgram/1 each conventional release oral tablet Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely pizotifen 1.5 milligram/1 each conventional release oral tablet Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing pizotifen Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Pizotifen Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing only pizotifen in oral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely pizotifen 50 microgram/1 milliliter conventional release oral solution (clinical drug) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing fremanezumab (medicinal product) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Fremanezumab Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing galcanezumab (medicinal product) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Galcanezumab Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing galcanezumab in parenteral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing only galcanezumab in parenteral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely galcanezumab 120 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing erenumab (medicinal product) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing erenumab in parenteral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing only erenumab in parenteral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Erenumab Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely erenumab 140 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely erenumab 70 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely clonidine hydrochloride 25 microgram/1 each conventional release oral tablet Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely clonidine hydrochloride 200 microgram/1 each conventional release oral tablet Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely clonidine hydrochloride 250 microgram/1 each prolonged-release oral capsule Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely clonidine hydrochloride 100 microgram/1 each conventional release oral tablet Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely clonidine hydrochloride 300 microgram/1 each conventional release oral tablet Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing only clonidine in oral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely clonidine hydrochloride 100 microgram/1 milliliter prolonged-release oral suspension (clinical drug) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing frovatriptan in oral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely frovatriptan succinate 2.5 milligram/1 each conventional release oral tablet Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing frovatriptan Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing only frovatriptan in oral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Frovatriptan Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing eletriptan in oral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing eletriptan Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely eletriptan (as eletriptan hydrobromide) 20 milligram/1 each conventional release oral tablet Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely eletriptan (as eletriptan hydrobromide) 40 milligram/1 each conventional release oral tablet Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing only eletriptan in oral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Eletriptan Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing almotriptan in oral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Almotriptan Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing almotriptan Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing only almotriptan in oral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely almotriptan (as almotriptan malate) 12.5 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely almotriptan (as almotriptan malate) 6.25 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing rizatriptan in oral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely rizatriptan (as rizatriptan benzoate) 5 milligram/1 each conventional release oral tablet Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely rizatriptan (as rizatriptan benzoate) 10 milligram/1 each conventional release oral tablet Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing rizatriptan Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Rizatriptan Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing only rizatriptan in oral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely rizatriptan (as rizatriptan benzoate) 5 milligram/1 each conventional release orodispersible tablet (clinical drug) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing rizatriptan in oromucosal dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing only rizatriptan in oromucosal dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing zolmitriptan in nasal dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing naratriptan in oral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing zolmitriptan in oral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely zolmitriptan 2.5 milligram/1 each conventional release oral tablet Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely naratriptan (as naratriptan hydrochloride) 2.5 milligram/1 each conventional release oral tablet Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely zolmitriptan 5 milligram/1 each conventional release oral tablet Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing zolmitriptan Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing naratriptan Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Zolmitriptan Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing only naratriptan in oral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing only zolmitriptan in nasal dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing only zolmitriptan in oral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Naratriptan Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely zolmitriptan 5 milligram/1 actuation conventional release nasal spray (clinical drug) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing zolmitriptan in oromucosal dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing only zolmitriptan in oromucosal dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely zolmitriptan 2.5 milligram/1 each conventional release orodispersible tablet (clinical drug) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely zolmitriptan 5 milligram/1 each conventional release orodispersible tablet (clinical drug) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely naratriptan (as naratriptan hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing sumatriptan in nasal dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing sumatriptan in oral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing sumatriptan in parenteral dose form (medicinal product form) Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely sumatriptan (as sumatriptan succinate) 100 milligram/1 each conventional release oral tablet Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely sumatriptan (as sumatriptan succinate) 50 milligram/1 each conventional release oral tablet Plays role True Antimigraine therapeutic role Inferred relationship Existential restriction modifier

Page 1 of 2 End

This concept is not in any reference sets

Back to Start